Literature DB >> 15121325

The success of immunization-shovelling its own grave?

Ulrich Heininger1.   

Abstract

Successful immunization programmes have reduced the burden of a number of infectious diseases on a global scale. Yet, as the fear of sequelae of vaccine-preventable diseases diminishes in the public, the focus of interest has shifted towards true and alleged "side effects". Maintaining confidence in the necessity, tolerability and safety of immunizations is of paramount importance today. This requires, amongst other prerequisites, precise definitions of "adverse events following immunisation". In Europe, a collaborative effort named EUSAFEVAC in concert with the globally active "Brighton Collaboration" has been initiated. Volunteers from academic institutions, vaccine licensing authorities, public health institutes, governmental organizations, safety units within the vaccine manufacturing industry as well as practicing physicians are working together to achieve this goal.

Entities:  

Mesh:

Year:  2004        PMID: 15121325     DOI: 10.1016/j.vaccine.2004.01.018

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines.

Authors:  Paul E Makidon; Shraddha S Nigavekar; Anna U Bielinska; Nicholas Mank; Abhishek M Shetty; Julie Suman; Jessica Knowlton; Andrzej Myc; Trent Rook; James R Baker
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-04       Impact factor: 2.849

2.  Vaccine risk assessment in children with a referred reaction to a previous vaccine dose: 2009-2011 retrospective report at the Bambino Gesu' children hospital, Rome, Italy.

Authors:  Luciana Nicolosi; Annachiara Vittucci; Rossella Mancini; Elena Bozzola; Alberto Cagigi; Annalisa Grandin; Alberto Villani
Journal:  Ital J Pediatr       Date:  2014-03-31       Impact factor: 2.638

3.  European citizens' opinions on immunisation.

Authors:  Nicola Moran; Darren Shickle; Erica Richardson
Journal:  Vaccine       Date:  2007-11-21       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.